相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Lea J. Mertens et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Albert Garcia-Romeu et al.
FRONTIERS IN PSYCHIATRY (2020)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia-Romeu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Replication and extension of a model predicting response to psilocybin
Suzanne L. Russ et al.
PSYCHOPHARMACOLOGY (2019)
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Lukasz Smigielski et al.
NEUROIMAGE (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
Psychedelic-Assisted Group Therapy: A Systematic Review
Alexander Trope et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2019)
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Leor Roseman et al.
NEUROPHARMACOLOGY (2018)
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
J. B. Stroud et al.
PSYCHOPHARMACOLOGY (2018)
Psychedelics and connectedness
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Effects of psilocybin therapy on personality structure
D. Erritzoe et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
Facundo Carrillo et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2018)
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman et al.
FRONTIERS IN PHARMACOLOGY (2018)
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Albert Garcia-Romeu et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Psychedelics as anti-inflammatory agents
Thomas W. Flanagan et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Psychedelics as Medicines: An Emerging New Paradigm
D. E. Nichols et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Long-term follow-up of psilocybin-facilitated smoking cessation
Matthew W. Johnson et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
Emotional blunting with antidepressant treatments: A survey among depressed patients
G. M. Goodwin et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
F. Mueller et al.
TRANSLATIONAL PSYCHIATRY (2017)
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin L. Carhart-Harris et al.
SCIENTIFIC REPORTS (2017)
Impact of Social Cognition on Alcohol Dependence Treatment Outcome: Poorer Facial Emotion Recognition Predicts Relapse/Dropout
Claudia I. Rupp et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2017)
Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
B. Romeo et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2017)
Patients' Accounts of Increased Connectedness and Acceptance After Psilocybin for Treatment-Resistant Depression
Rosalind Watts et al.
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
Rainer Kraehenmann et al.
NEUROIMAGE-CLINICAL (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats
Yuichi Sakashita et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis
Harry Man Xiong Lai et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Bridget F. Grant et al.
JAMA PSYCHIATRY (2015)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
David Baumeister et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer et al.
BIOLOGICAL PSYCHIATRY (2012)
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression
David A. Luckenbaugh et al.
BIPOLAR DISORDERS (2012)
Shaping the renaissance of psychedelic research
Ben Sessa
LANCET (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development
Evelyn K. Lambe et al.
PLOS ONE (2011)
Enhanced Function of Prefrontal Serotonin 5-HT2 Receptors in a Rat Model of Psychiatric Vulnerability
Madhurima Benekareddy et al.
JOURNAL OF NEUROSCIENCE (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist
Laura E. Phelps et al.
BIOLOGICAL PSYCHIATRY (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Serotonin receptor 2A gene and the influence of childhood maternal nurturance on adulthood depressive symptoms
Markus Jokela et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety
BAN Dhonnchadha et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
A checklist for retrospective database studies - Report of the ISPOR task force on retrospective databases
B Motheral et al.
VALUE IN HEALTH (2003)
分享论文
